QDM International Inc. (QDMI)

Revance Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	8.56	5.16	2.72	0.07	0.04
Cash & Short-Term Investments	8.56	5.16	2.72	0.07	0.04
Cash Growth	65.90%	89.80%	3801.55%	95.64%	-43.29%
Accounts Receivable	1.7	0.18	0.29	0	0
Receivables	1.7	0.18	0.29	0	0
Prepaid Expenses	0.14	0.1	0.02	0.05	0.04
Other Current Assets	-	-	-	-	0.07
Total Current Assets	10.4	5.45	3.03	0.12	0.15
Property, Plant & Equipment	0.22	0.27	0.09	0.12	-
Other Long-Term Assets	0.09	0.06	0.03	0.03	-
Total Assets	10.71	5.78	3.15	0.27	0.15
Accounts Payable	0.29	0.57	0.22	0.01	0.01
Current Portion of Leases	0.12	0.11	0.03	0.04	-
Current Income Taxes Payable	1.4	0.31	-	-	-
Other Current Liabilities	-	1.28	1.05	0.82	0.57
Total Current Liabilities	1.8	2.27	1.3	0.87	0.58
Long-Term Leases	0.07	0.09	0.04	0.07	-
Total Liabilities	1.87	2.36	1.34	0.94	0.58
Common Stock	0	0	0	0	0
Additional Paid-In Capital	12.5	11.9	11.9	9.47	9.34
Retained Earnings	-3.6	-8.43	-9.99	-10.04	-9.66
Treasury Stock	-0.06	-0.06	-0.06	-0.06	-0.06
Comprehensive Income & Other	-	-	-0.05	-0.05	-0.05
Shareholders' Equity	8.84	3.42	1.81	-0.67	-0.43
Total Liabilities & Equity	10.71	5.78	3.15	0.27	0.15
Total Debt	0.19	0.2	0.07	0.11	-
Net Cash (Debt)	8.37	4.96	2.64	-0.04	0.04
Net Cash Growth	68.80%	87.56%	-	-	-43.29%
Net Cash Per Share	0.03	0.02	0.06	-0.01	0.00
Filing Date Shares Outstanding	299.52	293.52	293.52	4.06	4.04
Total Common Shares Outstanding	299.52	293.52	293.52	4.06	3.87
Working Capital	8.61	3.18	1.73	-0.75	-0.43
Book Value Per Share	0.03	0.01	0.01	-0.17	-0.11
Tangible Book Value	8.84	3.42	1.81	-0.67	-0.43
Tangible Book Value Per Share	0.03	0.01	0.01	-0.17	-0.11

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.